A False-Negative Case of Primary Central Nervous System Lymphoma on 11C-Methionine PET and Intense 18F-FDG Uptake
Authors:
- Diego Villasboas-RosciolesiDVDiego Villasboas-Rosciolesi
- Miguel BaqueroMBMiguel Baquero
- Pere BassaPBPere Bassa
- Marina SolerMSMarina Soler
- Eduard RieraEREduard Riera
- 1 August 2016
- journal article
- case report
- Published by Wolters Kluwer Health in Clinical Nuclear Medicine
- Vol. 41 (8) , 664-665
Abstract
We report a case of a 44-year-old man with neurological symptoms and MRI findings, which were unable to differentiate between glioma and lymphoma. Metabolic characterization by means of PET imaging with F-FDG and C-methionine is proposed to determine the benign or tumor (high- and low-grade) origin of brain lesions. In this case, the MRI lesion corresponded with an inconclusive metabolic pattern of intense F-FDG uptake and no significant C-methionine uptake. Pathological study revealed a false-negative case of C-methionine due to lymphoma.Keywords
This publication has 11 references indexed in Scilit:
- Differentiation of Newly Diagnosed Glioblastoma Multiforme and Intracranial Diffuse Large B-cell Lymphoma Using 11C-Methionine and 18F-FDG PETClinical Nuclear Medicine, 2012
- Neuroimagen de los tumores cerebralesRevista Española de Medicina Nuclear, 2011
- Comparison of 11C-Methionine PET and 18F-FDG PET in Patients with Primary Central Nervous System LymphomaMolecular Imaging and Biology, 2010
- Clinical impact of 11C-methionine PET on expected management of patients with brain neoplasmEuropean Journal of Nuclear Medicine and Molecular Imaging, 2009
- Metabolic Assessment of Gliomas Using11C-Methionine, [18F] Fluorodeoxyglucose, and11C-Choline Positron-Emission TomographyAmerican Journal of Neuroradiology, 2008
- 11C-l-Methionine Positron Emission Tomography in the Clinical Management of Cerebral GliomasMolecular Imaging and Biology, 2007
- FDG-PET in immunocompetent patients with primary central nervous system lymphoma: correlation with MRI and clinical follow-upEuropean Journal of Nuclear Medicine and Molecular Imaging, 2005
- Usefulness of 11C-methionine PET in the evaluation of brain lesions that are hypo- or isometabolic on 18F-FDG PETEuropean Journal of Nuclear Medicine and Molecular Imaging, 2001
- Positron Emission Tomography in Patients with Primary CNS LymphomasJournal of Neuro-Oncology, 1999
- 11 C-methionine PET for differential diagnosis of low-grade gliomasNeurology, 1998